Literature DB >> 28869878

From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends.

Marit Edland-Gryt1, Sveinung Sandberg2, Willy Pedersen3.   

Abstract

BACKGROUND: Ecstasy pills with MDMA as the main ingredient were introduced in many European countries in the 1980s, and were often linked to the rave and club scenes. However, use gradually levelled off, in part as a response to increased concerns about possible mental health consequences and fatalities. Extensive use of MDMA now seems to be re-emerging in many countries. In this study, we investigated the cultural and social meaning associated with MDMA use in Oslo, Norway, with an emphasis on how users distinguish MDMA crystals and powder from "old ecstasy pills".
METHODS: Qualitative in-depth interviews (n=31, 61,3% males) were conducted with young adult party-goers and recreational MDMA/ecstasy users (20-34 years old, mean age 26.2 years).
RESULTS: Research participants emphasised three important perceived differences between the MDMA crystals and ecstasy pills: (i) The effects of MDMA were described as better than ecstasy; (ii) MDMA was regarded as a safer drug; (iii) Users of MDMA crystals were described as more distinct from and less anchored in out-of-fashion rave culture than those using ecstasy. These differences were an important part of the symbolic boundary work MDMA users engaged in when justifying their drug use.
CONCLUSION: MDMA has re-emerged as an important psychoactive substance in Oslo's club scene. One important reason for this re-emergence seems to be its perceived differentiation from ecstasy pills, even though the active ingredient in both drugs is MDMA. This perceived distinction between MDMA and ecstasy reveals the importance of social and symbolic meanings in relation to psychoactive substance use. Insights from this study can be important in terms of understanding how trends in drug use develop and how certain drugs gain or lose popularity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Club drug use; Ecstasy pills; Lay epidemiology; MDMA crystals; Recreational substance use; Symbolic boundaries

Mesh:

Substances:

Year:  2017        PMID: 28869878     DOI: 10.1016/j.drugpo.2017.07.030

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.

Authors:  Ove Heradstveit; Jens Christoffer Skogen; Marit Edland-Gryt; Morten Hesse; Lotte Vallentin-Holbech; Kari-Jussie Lønning; Børge Sivertsen
Journal:  Front Psychiatry       Date:  2020-12-10       Impact factor: 4.157

3.  The Effects of Folic Acid on Testicular Histology, Sperm Quality, and Spermatogenesis Indices Following 3,4-Methylenedioxymethamphetamine Exposure in Adult Male Rats.

Authors:  Iman Rad; Arezoo Saberi; Najmeh Sadat Koochakzadeh-Nematollahi; Victoria Habibzadeh; Ehsan Salarkia; Sedigheh Amanollahi; Saeideh Nikpour
Journal:  Addict Health       Date:  2021-01

4.  No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic.

Authors:  Antonia Bendau; Leonard Viohl; Moritz Bruno Petzold; Jonas Helbig; Simon Reiche; Roman Marek; Amy Romanello; Daa Un Moon; Rosa Elisa Gross; Dario Jalilzadeh Masah; Stefan Gutwinski; Inge Mick; Christiane Montag; Ricarda Evens; Tomislav Majić; Felix Betzler
Journal:  Int J Drug Policy       Date:  2022-01-05

5.  Ecstasy (MDMA): A rebellion coherent with the system.

Authors:  José Manuel García-Montes; Marino Pérez-Álvarez; Miguel Ángel Sánchez-Moya; José Alberto Carmona Torres; David F Carreno; Salvador Perona Garcelán; Laura Del Carmen Sánchez-Sánchez
Journal:  Nordisk Alkohol Nark       Date:  2020-11-28

6.  Ecstasy-induced fixed drug eruption.

Authors:  Ophélie Barbier; Alia Galadari; Brigitte Milpied; Paola Sanchez; Stéphanie Kassab; Ruben Goncalves; Anne-Sophie Darrigade
Journal:  Contact Dermatitis       Date:  2022-04-29       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.